GeneTrait Laboratories

GeneTrait Laboratories was a specialized clinical laboratory focused on pharmacogenetics (PGx) testing to optimize medication management. The company provided genetic insights to healthcare providers to help predict how patients would respond to specific medications, particularly in the fields of psychiatry, pain management, and cardiology. By analyzing genetic variations in drug-metabolizing enzymes, GeneTrait aimed to reduce adverse drug reactions and improve therapeutic efficacy. The company utilized molecular diagnostic technologies to deliver actionable reports that guided clinical decision-making. In 2018, GeneTrait Laboratories was acquired by Precision Genetics to enhance their comprehensive medication management and clinical decision support offerings. This acquisition integrated GeneTrait's laboratory expertise into a broader digital health and personalized medicine platform.